Evaluation of Prognostic Scores in Patients With Upper Gastrointestinal Bleeding and Cancer

Launched by INSTITUTO DO CANCER DO ESTADO DE SÃO PAULO · Jul 23, 2015

Keywords

ClinConnect Summary

Background: Cancer incidence is rising worldwide, therefore complications of this condition, such as bleeding, are also expected to be more frequently seen.

Tumoral bleeding is usually difficult to control and the bleeding episode may represent the end stage of the malignant disease. In this context, it is relevant to study the performance of prognostic scores to prediction of clinical outcomes in patients with cancer.

Objective: To evaluate and compare the performance of prognostic scores to predict clinical outcomes in a group of patients with cancer of any site that has presented a rec...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of malignant neoplasm of any site, either located inside or outside of GI tract;
• • Current evidence of bleeding in the last 48 hours, either by presenting hematemesis and/or melena, with or without hemodynamic instability. Patients with hematochezia or bright red blood per rectum due to a site of bleeding in upper GI tract will also be included.
• Exclusion Criteria:
• • Age \< 18 years-old;
• • Suspicion or confirmation of pregnancy.
• • Patients with no evidence of malignant neoplasm after curative surgery or oncologic therapy.